Integrating Nonpharmacologic Strategies for Pain With Inclusion, Respect, and Equity

a study on Pain Mindfulness

Summary

Eligibility
for people ages 18 years and up (full criteria)
Location
at San Francisco 5391959, California 5332921 and other locations
Dates
study started
study ends around
Principal Investigator
by Jason Satterfield, PhD

Description

Summary

INSPIRE creates a trilingual mobile app and telehealth coaching program to promote non-pharmacologic strategies for pain management with Black, Chinese, and Latinx communities in the San Francisco Bay Area. Years 1-2 will develop the app and test it with a brief single arm pilot starting in Nov 2023. A full two arm randomized controlled trial (RCT) will being in early 2025 with changes in PEG scores as the primary outcome. Secondary outcomes include Helping to End Addiction Longterm (HEAL) common data elements.

Official Title

Integrating Nonpharmacologic Strategies for Pain With Inclusion, Respect, and Equity (INSPIRE): Tailored Digital Tools, Telehealth Coaching, and Primary Care Coordination

Keywords

Chronic Pain, Non-malignant chronic pain, Digital health, Health coaching, Health equity, Cognitive therapy, Mindfulness, Movement, CBT, Mindfulness, and Movement

Eligibility

You can join if…

Open to people ages 18 years and up

  1. age 18 or older
  2. speak English, Spanish, or Cantonese
  3. have a UCSF Health or SFHN PCP
  4. be willing to use a smartphone (iOS or Android - either their own or one provided by the study)
  5. have chronic, non-malignant pain for at least 3 months
  6. be willing to participate in a 12 month patient-centered chronic pain management study where they will be randomized into one of two comparison arms

You CAN'T join if...

  • Severe mental illness or other condition preventing informed consent

Locations

  • San Francisco General Hospital accepting new patients
    San Francisco 5391959 California 5332921 94110 United States
  • UCSF Adult Primary Care Mt. Zion Clinic accepting new patients
    San Francisco 5391959 California 5332921 94115 United States

Lead Scientist at UCSF

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
University of California, San Francisco
ID
NCT06183281
Study Type
Interventional
Participants
Expecting 586 study participants
Last Updated
Contact us about this trial